Analysis of the data from the open-label pivotal trial of oxylanthanum carbonate (OLC) highlights that pill burden was significantly reduced in terms of both pill volume (7x) and pill count (2x) from ...

Novo Nordisk today announced plans to present 11 abstracts at the 76th Annual American Association for the Study of Liver ...

Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the ...

CHICAGO -- Plaque psoriasis drug deucravacitinib (Sotyktu) now looks likely to win a psoriatic arthritis (PsA) indication in ...

My experiences have demonstrated that business development combined with market analysis is the most powerful pairing for ...

Simplify Excel file sharing and exporting. Learn how to collaborate in the cloud, email files, and manage formats with ease.

GLP-1 receptor agonists may have beneficial effects against Alzheimers, psychiatric and addiction disorders, but early data ...

Visual content depicting climate activists emphasizes emotion and disruption, contrasting with the rational, data-driven ...

MASH data to be presented at the 76th Annual AASLD The Liver Meeting®, 7-11 November Highlights include data from post-hoc analyses ...

American Critical Minerals has voluntarily filed a National Instrument 43-101 Technical Report supporting the exploration targets for Potash, Lithium and Bromine. 2.1 billion cubic meters (brine ...

VYVGART demonstrated clinically meaningful benefit across all AChR-Ab seronegative gMG subtypes in ADAPT SERON, supporting broad role of pathogenic IgGs in disease activityFinal ADAPT SC+ results show ...

Investing.com -- Viking Therapeutics Inc (NASDAQ:VKTX) stock jumped 7.3% following the announcement that its VK2735 obesity program will be featured in multiple presentations at upcoming medical ...